SEREVENT®(salmeterol xinafoate)

• Serevent Inhalation Aerosol approved for COPD, 1998

• Approval sought for Serevent Diskus for the maintenance treatment of bronchospasm associated with COPD

Previous slide

Next slide

Back to first slide

View graphic version